drugset / Trial / NCT06670274
A Dose Escalating Study of HC002 in Healthy Adult Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a first-in-human (FIH) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of single and multiple ascending oral doses of HC002 in healthy adult participants.
Timeline
- Start
- 2024-11-21
- Primary completion
- 2025-03-31
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HC002 | Unknown | — | Oral |